Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 13-3875950 · Snapshot of IRS recognition, filing currency, financial health, and governance.
To enhance affordable care to people with bleeding disorders by supplying blood-clotting concentrates & other medications for the treatment of Hemophilia & other blood-clotting disorders.
Total Revenue
$21.2M
FY2023
Total Expenses
$21.2M
FY2023
Net Assets
$124K
Program Ratio
98.7%
expenses on programs
Employees
0
Volunteers
0
Board Members
15
Voting
15
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.